Multimeric protein structures comprising at least two alpha-galactosidase monomers being covalently linked to one another via a linking moiety are disclosed herein as well a process for preparing same and methods of treating Fabry disease via administration of a multimeric protein structure. The disclosed multimeric protein structures exhibit an improved performance in terms of enhanced activity and/or a longer lasting activity under both lysosomal conditions and in a serum environment.
申请公布号
IN2262MUN2012(A)
申请公布日期
2015.06.12
申请号
IN2012MUMNP2262
申请日期
2012.09.25
申请人
PROTALIX LTD.
发明人
SHULMAN AVIDOR;RUDERFER&NBSP, ILYA;BEN-MOSHE&NBSP, TEHILA;SHEKHTER&NBSP, TALIA;AZULAY&NBSP, YANIV;SHAALTIEL&NBSP, YOSEPH;KIZHNER&NBSP, TALI